Neuro Central 2022 wrapped: a year in review

You’ve heard of Spotify wrapped…now it’s time for Neuro Central 2022 wrapped.   As we enter 2023, we reflect on Neuro Central’s highlights and top-performing content of 2022. We explored various topics, including Alzheimer’s, multiple sclerosis and epilepsy. The most popular topic with our readers has continued to be neurodegenerative disease, particularly Alzheimer’s disease, and there were some big developments in the field last year. The fall of aducanumab... Our top-performing content piece of the year was our article on the rise and fall of aducanumab. After first entering clinical trial stages in 2015, the Alzheimer’s drug has had a...